BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29484905)

  • 1. Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma.
    Jiang T; Zhang B; Zhang L; Wu X; Li H; Shen S; Luo Z; Liu X; Hu Y; Pang Z; Jiang X
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1088-1101. PubMed ID: 29484905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer.
    Zhang B; Wang H; Jiang T; Jin K; Luo Z; Shi W; Mei H; Wang H; Hu Y; Pang Z; Jiang X
    J Drug Target; 2018 Dec; 26(10):913-919. PubMed ID: 29533111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas.
    Jiang T; Zhang B; Shen S; Tuo Y; Luo Z; Hu Y; Pang Z; Jiang X
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31497-31508. PubMed ID: 28849917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
    Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
    BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.
    Wang H; Wu J; Williams GR; Fan Q; Niu S; Wu J; Xie X; Zhu LM
    J Nanobiotechnology; 2019 May; 17(1):60. PubMed ID: 31084622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
    Duan T; Xu Z; Sun F; Wang Y; Zhang J; Luo C; Wang M
    Biomed Pharmacother; 2019 Sep; 117():109121. PubMed ID: 31252265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
    Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
    J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer.
    Zhang B; Jiang T; Shen S; She X; Tuo Y; Hu Y; Pang Z; Jiang X
    Biomaterials; 2016 Oct; 103():12-21. PubMed ID: 27376555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway.
    Verma RK; Yu W; Singh SP; Shankar S; Srivastava RK
    Nanomedicine; 2015 Nov; 11(8):2061-70. PubMed ID: 26199979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
    Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
    J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression.
    Lu Z; Long Y; Wang Y; Wang X; Xia C; Li M; Zhang Z; He Q
    Eur J Pharm Biopharm; 2021 Aug; 165():164-173. PubMed ID: 34020022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
    Almawash SA; Mondal G; Mahato RI
    Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
    Xu FG; Ma QY; Wang Z
    Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases.
    Warzecha J; Dinges D; Kaszap B; Henrich D; Marzi I; Seebach C
    Int J Mol Med; 2012 Mar; 29(3):423-7. PubMed ID: 22138977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
    Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
    Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
    Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.